Background. We assessed the risk of second brain tumours in a cohort of
Introduction
Conventional external beam radiotherapy is effective in achieving control of tumour growth and hormonal hypersecretion in patients with pituitary adenoma. Despite its effectiveness there is concern about late effects of radiation with second radiation induced brain tumour a particularly feared complication. It is recognised that radiation is associated with the development of intracranial tumours following therapeutic cranial irradiation for acute lymphoblastic leukaemia (1), tinea capitis (2) (3), and intracranial tumours (4) (5) (6) . Increased risk of second brain tumours has also been demonstrated in animals exposed to radiation (7) .
We previously reported an actuarial cumulative risk of developing a second brain tumour in patients with pituitary adenoma treated with surgery and radiotherapy as 1.0% at 10 years and 1.9% at 20 years after treatment with a relative risk compared to normal population of 10.5 (8) . The results were confirmed by some investigators (9) although other series reported lower incidence (10) (11) . While there is a debate about the relative and actuarial risk of developing a second brain tumour it must be acknowledged that the relationship between radiotherapy and second brain tumour remains putative with no clear demonstration of one treatment factor as the only cause. The reason for singling out radiation as the most likely culprit is the evidence for radiotherapy as the main determinant in other conditions and the relative lack of evidence of association between pituitary adenoma and second malignancy.
Regardless of the debate on causation we continued detailed follow up of the cohort of patients with pituitary adenoma reported previously. In this report we set out to assess the potential change in the actuarial incidence and relative risk of second tumour with additional 10 years of follow-up in an enlarged cohort containing the previously reported series. The median follow-up for the entire series was 12 years ranging from 0 to 38.4 years; 126 patients were followed up more than 20 years. The total follow-up consisted of 5,647 person -years.
Patients and methods

Statistical considerations
The risk to patients of a second brain tumour was estimated by the KaplanMeier survival method (12) and the time of the event was measured from the beginning of radiotherapy. Predictors of risk of second tumour were analysed in a univariate analysis by the log-rank test (13) . The second tumour data were compared to the expected numbers of tumours in the general population using national age and sex specific incidence rates (Office for National Statistics, England and Wales 1992). All p-values were 2 -sided and based on the Poisson distribution (14) .
Results
Incidence of second tumours
Eleven of the 426 patients developed a second intracranial tumour after surgery and radiotherapy for pituitary adenoma (Table 2) . Five patients had a meningioma, four a high grade astrocytoma, one a meningeal sarcoma, and one a PNET. The diagnosis was confirmed histologically in all but one, in whom the presence of a meningioma was diagnosed by CT imaging. In all cases tumours were identified within the region of entry of radiation fields, and in one case in the pituitary fossa. Tumours were diagnosed 6 to 34 years after radiotherapy with a mean (and SD) of 6.7 ± 1.7 years for astrocytoma and 20.8 ± 10.0 years for meningeal tumours, respectively. Age, sex, pituitary adenoma type, radiation dose, tumour extent, and medical treatment were found not to be predictive of development of second tumours on univariate analysis.
Thirty-seven patients developed a second tumour at peripheral sites during the follow-up (Table 3) .
Comparison of risk of second tumour to general population
The cumulative risk of second brain tumours was 2.0% (95% CI: 0.9 -4.4%) at 10 years, 2.4% years (95% CI: 1.2 -5.0%) at 20 years, and 8.5% ( One patient developed a PNET 5 years after radiotherapy. The development of a PNET following prophylactic craniospinal irradiation has been reported (19) and a recent publication suggests that it may be more common than suggested previously (35) .
In summary, the study confirms the previous report of an increased risk of Error bars repersent 95% confidence intervals.
